BRPI0606658B8 - método para armazenar e distribuir interferon-beta, e dispositivo - Google Patents

método para armazenar e distribuir interferon-beta, e dispositivo

Info

Publication number
BRPI0606658B8
BRPI0606658B8 BRPI0606658A BRPI0606658A BRPI0606658B8 BR PI0606658 B8 BRPI0606658 B8 BR PI0606658B8 BR PI0606658 A BRPI0606658 A BR PI0606658A BR PI0606658 A BRPI0606658 A BR PI0606658A BR PI0606658 B8 BRPI0606658 B8 BR PI0606658B8
Authority
BR
Brazil
Prior art keywords
interferon
beta
distributing
storing
reduces
Prior art date
Application number
BRPI0606658A
Other languages
English (en)
Inventor
Anthony Faulkner Eric
Diana Di Biase Mary
Original Assignee
Biogen Idec Inc
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36601194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0606658(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Idec Inc, Biogen Ma Inc filed Critical Biogen Idec Inc
Publication of BRPI0606658A2 publication Critical patent/BRPI0606658A2/pt
Publication of BRPI0606658A8 publication Critical patent/BRPI0606658A8/pt
Publication of BRPI0606658B1 publication Critical patent/BRPI0606658B1/pt
Publication of BRPI0606658B8 publication Critical patent/BRPI0606658B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0007—Special media to be introduced, removed or treated introduced into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)

Abstract

método para distribuir interferon-beta. a presente invenção refere-se a um método aqui descrito reduz a quantidade de metal agregante liberado em uma solução de interferon-(beta).
BRPI0606658A 2005-01-12 2006-01-11 método para armazenar e distribuir interferon-beta, e dispositivo BRPI0606658B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64327305P 2005-01-12 2005-01-12
US60/643,273 2005-01-12
PCT/US2006/001016 WO2006076453A2 (en) 2005-01-12 2006-01-11 METHOD FOR DELIVERING INTERFERON-β

Publications (4)

Publication Number Publication Date
BRPI0606658A2 BRPI0606658A2 (pt) 2009-07-07
BRPI0606658A8 BRPI0606658A8 (pt) 2017-02-14
BRPI0606658B1 BRPI0606658B1 (pt) 2021-03-09
BRPI0606658B8 true BRPI0606658B8 (pt) 2021-05-25

Family

ID=36601194

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606658A BRPI0606658B8 (pt) 2005-01-12 2006-01-11 método para armazenar e distribuir interferon-beta, e dispositivo

Country Status (19)

Country Link
US (3) US8784399B2 (pt)
EP (1) EP1845925B1 (pt)
JP (2) JP5192823B2 (pt)
KR (1) KR101238148B1 (pt)
CN (2) CN101102739B (pt)
AU (2) AU2006204937B2 (pt)
BR (1) BRPI0606658B8 (pt)
CA (1) CA2594894C (pt)
CY (1) CY1118097T1 (pt)
DK (1) DK1845925T3 (pt)
ES (1) ES2588583T3 (pt)
HU (1) HUE031061T2 (pt)
IL (2) IL184372A (pt)
LT (1) LT1845925T (pt)
MX (1) MX2007008220A (pt)
PL (1) PL1845925T3 (pt)
PT (1) PT1845925T (pt)
SG (1) SG158872A1 (pt)
WO (1) WO2006076453A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1845925T (pt) 2005-01-12 2016-11-22 Biogen Ma Inc Método para distribuir interferão-beta

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266557A (en) 1978-01-16 1981-05-12 The Kendall Company Low friction syringe
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
US4521237A (en) 1983-05-23 1985-06-04 Kahle Engineering Co. Glass dose syringe
CN85201778U (zh) 1985-04-30 1986-04-16 欧阳士波 全自动的注射器清洗设备
US5183746A (en) 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US4895716A (en) 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US5011608A (en) * 1988-11-18 1991-04-30 Dragana Damjanovic Biogenic amine assay using HPLC-ECD
CN2076853U (zh) 1990-06-15 1991-05-15 阎淑华 多孔式注射器清洗架
KR0138353Y1 (ko) 1996-12-13 1999-04-01 주식회사부윤테크 일회용 주사기
JP4878664B2 (ja) 1996-12-24 2012-02-15 バイオジェン・アイデック・エムエイ・インコーポレイテッド 安定な液体インターフェロン処方物
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
AU3001299A (en) 1998-03-13 1999-09-27 Becton Dickinson & Company Method for manufacturing, filling and packaging medical containers
JP2951938B1 (ja) * 1998-03-19 1999-09-20 日本ケミカルリサーチ株式会社 薬剤溶解機構を内蔵した注射器
DK1121382T3 (da) 1998-10-16 2006-11-13 Biogen Idec Inc Interferon-beta-fusionsproteiner og deres anvendelser
DE19903876B4 (de) * 1999-02-01 2006-09-28 Orthogen Gentechnologie Gmbh Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten
AU780270B2 (en) * 2000-02-23 2005-03-10 Association Francaise Contre Les Myopathies Treatment of immune diseases
JP4492985B2 (ja) 2000-02-24 2010-06-30 三菱商事プラスチック株式会社 液体医薬品用プラスチック容器及び液体医薬品の保存回収方法
WO2003000323A1 (en) * 2001-06-20 2003-01-03 Becton Dickinson And Company Safety shield system for prefilled syringes
CA2490804C (en) * 2002-06-28 2016-12-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating autoimmune diseases with interferon-beta and il-2r antagonist
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
AR044302A1 (es) 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
CN101061073A (zh) * 2004-09-30 2007-10-24 贝克顿·迪金森公司 减少或消除玻璃容器中残余物的方法以及根据该方法制成的玻璃容器
PT1845925T (pt) 2005-01-12 2016-11-22 Biogen Ma Inc Método para distribuir interferão-beta
CA2619452A1 (en) * 2005-09-12 2007-03-22 Alza Corporation Coatable transdermal delivery microprojection assembly

Also Published As

Publication number Publication date
US20080188823A1 (en) 2008-08-07
ES2588583T3 (es) 2016-11-03
EP1845925A2 (en) 2007-10-24
LT1845925T (lt) 2016-09-26
CN101102739B (zh) 2017-02-08
AU2011202152A1 (en) 2011-06-02
CN107028760A (zh) 2017-08-11
CA2594894C (en) 2015-11-03
KR20070102545A (ko) 2007-10-18
US8784399B2 (en) 2014-07-22
HUE031061T2 (en) 2017-06-28
CY1118097T1 (el) 2017-06-28
PL1845925T3 (pl) 2017-05-31
CN107028760B (zh) 2019-11-01
EP1845925B1 (en) 2016-08-24
IL184372A0 (en) 2007-10-31
BRPI0606658A2 (pt) 2009-07-07
IL184372A (en) 2016-02-29
CA2594894A1 (en) 2006-07-20
US10220074B2 (en) 2019-03-05
SG158872A1 (en) 2010-02-26
JP2011252026A (ja) 2011-12-15
PT1845925T (pt) 2016-11-22
BRPI0606658A8 (pt) 2017-02-14
IL243648A0 (en) 2016-02-29
US20150080840A1 (en) 2015-03-19
WO2006076453A2 (en) 2006-07-20
AU2006204937B2 (en) 2011-02-10
KR101238148B1 (ko) 2013-03-04
JP2008526441A (ja) 2008-07-24
MX2007008220A (es) 2007-08-17
CN101102739A (zh) 2008-01-09
DK1845925T3 (en) 2016-11-28
US9452106B2 (en) 2016-09-27
AU2006204937A1 (en) 2006-07-20
JP5192823B2 (ja) 2013-05-08
WO2006076453A3 (en) 2006-09-21
US20160361389A1 (en) 2016-12-15
BRPI0606658B1 (pt) 2021-03-09

Similar Documents

Publication Publication Date Title
CY1112511T1 (el) Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline)
BRPI0813311A2 (pt) Composto, métodos para modulara a atividade de uma proteína quinase e para tratar câncer em um indivíduo, e, composição farmacêutica.
EA201000146A1 (ru) Связующее майларда на основе гидроксимонокарбоновой кислоты
BRPI0701895A (pt) batente para solda ultra-sÈnica e dispositivo para solda ultra-sÈnica
GT200700094A (es) Dispositivo con un mecanismo de rodamiento para sujetar planchas y elementos separadores
TW200714283A (en) Method and composition for treating peripheral vascular diseases
TN2010000096A1 (en) Oxadiazole - and oxazole - substituted benzimidazole - and indole - derivatives as dgat1 inhibitors
CR9757A (es) Composiciones que proporcionan tolerancia a multiples herbicidas y metodos para usarlas
BRPI0808696A2 (pt) Complexos de hiluronanas, outros componentes de matriz, hormônios e fatores de crescimento para manutenção, expansão e/ou diferenciação de células
TN2014000134A1 (en) Therapeutic peptides
EA201591559A1 (ru) Терапевтические пептиды
UA96596C2 (xx) Поліпшений видавальний пристрій$улучшенное подающее устройство
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
WO2008008348A3 (en) Method and compositions for treating stroke with fever
MX2009007570A (es) Metodos para tratar la psoriasis.
HUE072418T2 (hu) Metallotionein inhibitorok cukorbetegség, hepatitisz és/vagy gyulladásos májbetegség kezelésére
AR053880A1 (es) Composiciones fungicidas sinergicas
PL1666073T3 (pl) Urządzenie do podawania kompozycji przeciwdrobnoustrojowej
CL2008000093A1 (es) Compuestos derivados de piridina, inhibidores de p2y12; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de un desorden de agregacion plaquetaria.
UA103456C2 (ru) Способ повышения толерантности растений
BRPI0606658B8 (pt) método para armazenar e distribuir interferon-beta, e dispositivo
EG25062A (en) Support device for applying an electical apparatusto an apparatus-mounting rail.
MX2007009914A (es) Uso de agonistas selectivos para el receptor-beta de estrogeno para la mucositis inducida por radiacion o por quimioterapia y para la cistitis inducida por radiacion.
EA200800820A1 (ru) Композиция с замедленным высвобождением и ее применение
GB0810227D0 (en) Synergistic binder composition, method for making same and tablets of an active and said binder having advantages hardness and friability

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: BIOGEN MA INC. (US)

B25I Requirement for requested change of headquarter

Owner name: BIOGEN MA INC. (US)

B25G Requested change of headquarter approved

Owner name: BIOGEN MA INC. (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/03/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/01/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF